
NorthEdge's Direct Healthcare Group bolts on Qbitus
NorthEdge Capital-backed Direct Healthcare Group (DHG), a British manufacturer of mattresses and pillows for the healthcare sector, has acquired Qbitus Products, a UK-based pressure-relieving cushions supplier.
This is the fourth bolt-on inked by DHG in the last two years, following the acquisitions of pressure care management business Direct Healthcare Services, bariatric rental specialist Nightingale Care Beds, seating product manufacturer Kirton Healthcare, and pressure care brand Transflo Cushion.
Following this last acquisition, the company expects to reach a turnover of £24m in 2018.
NorthEdge acquired DHG in April 2016, in a management buyout that marked the GP's first investment in the healthcare sector. Capital for the acquisition was drawn from NorthEdge's first fund, a £225m vehicle that held its final close in March 2013.
Under NorthEdge's management, the company has grown by making strategic acquisitions, strengthened its product offering and increased its headcount from 62 to 180 people.
Company
Based in Halifax and founded in the 1980s, Qbitus supplies bespoke, pressure-relieving cushions to the NHS and its wheelchair services, as well as direct buyers. The company has two UK-based manufacturing plants.
People
Direct Healthcare Group – Graham Ewart (CEO).
NorthEdge Capital – Andy Skinner (investment director).
Latest News
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Multi-family office has seen strong appetite, with investor base growing since 2016 to more than 90 family offices, Meiping Yap told Unquote
Permira to take Ergomed private for GBP 703m
Sponsor deploys Permira VIII to ride new wave of take-privates; Blackstone commits GBP 200m in financing for UK-based CRO
Partners Group to release IMs for Civica sale in mid-September
Sponsor acquired the public software group in July 2017 via the same-year vintage Partners Group Global Value 2017
Change of mind: Sponsors take to de-listing their own assets
EQT and Cinven seen as bellweather for funds to reassess options for listed assets trading underwater